Benchmark analyst Bruce Jackson reiterated a Hold rating on VolitionRX (NYSE: VNRX).The analyst commented, "VolitionRx continues to practice tight expense ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments